RESEARCH GRANTS

The FOXG1 Research Foundation is providing grants to scientists to understand the biology of FOXG1 with the ultimate goal of identifying innovative therapeutic strategies and finding a cure.

For the next few years, these are the strategic focus areas:

-Experiments designed to understand when, where, and levels of FOXG1 needed for normal brain development in mice

-Experiments designed to understand the biophysical properties of FOXG1 mutations

-Experiments designed to gain insights into the molecular and cell biological pathways regulated by FOXG1 

Note: As a non-profit patient organization, we do not pay university overhead fees as part of our grants.


FOXG1 EXPRESSION

Outside of the central nervous system, the expression of FOXG1 is very limited. It is expressed in the nasal retina, the anterior foregut, the anterior pituitary, and the otic vesicle (gives rise to the ear).

In the developing and adult brain:

·     Cerebral cortex

·     Hippocampus

·     Striatum

·     Basal ganglia

·     Olfactory bulb 

Image: Brain Atlas

Kawaguchi et al. Dev Bio 2016

Top: sections of mouse embryos at E11.5. The site of FOXG1 expression is coloured in blue. 

Bottom: sections of mouse brain at early postnatal (A) and adult (B) stages showing FOXG1 sites of expression in blue.

Abbreviations: Tel: telencephalon, oe: olfactory epithelium, ov, otic vesicle, rp: raphke’s puch, fg: foregut, pit: pituitary

Tigani et al. Cereb. Cortex 2020

Left: section of the developing cortex (at embryonic day 16.5) in mice, showing expression of FOXG1 in red (bright) in the cortical plate. Right: higher magnification of the boxed region (a’). FOXG1 is expressed at low levels in neural progenitor cells lining the ventricle (asterisk) and at higher levels in the cortical plate.

In cells in the brain:

·     Neural progenitor cells (NPCs)

·     Neurons

·     Oligodendrocyte progenitor cells (OPCs)

·     Astrocytes

Data from www.BrainRNASeq.org


FOXG1 FUNCTION:

·     Neural stem cell self-renewal

·     Proliferation versus differentiation switch

·     Establishment of forebrain cell-type identity

·     Excitatory/inhibitory (E/I) neuronal balance

·     Cortical laminar organization

·     Neuronal survival

·     Mitochondrial bioenergetics

 
 
 
 
 
 

Phenotypes detected in Foxg1+/- mice

·     Smaller forebrains than wildtype, mainly due to reduced cortical and hippocampal size

·     Abnormal cortical laminar organization

·     Corpus callosum agenesis

·     Delayed myelination

·     Poor performance in memory tasks

·     Aggression

·     Hyperactivity

·     Reduced sociability and social novelty seeking

·     Abnormal EEG (but not spontaneous seizures)

Phenotypes detected in postmortem brains (p.Glu154Glyfs*301 and p.Glu154*)

·     Abnormal cortical laminar organization

·     Absent myelination (possibly delayed)

·     Almost absent OLIG2+ cells

·     Reduced cortical cell numbers, particularly deep layer neurons and GABAergic neurons of the forebrain

·     Corpus callosum agenesis

·     Gliosis (increased GFAP-positivity)

·     Calcified neurons


Unlocking the mysteries of common neurodevelopmental disorders via FOXG1

AUTISM SPECTRUM DISORDERS: PROPORTION MONOGENIC – 15-34%

  • FOXG1 variant identified in an individual with ASD and his similarly affected mother

  • FOXG1 gene dose associated with ASD diagnosis

SCHIZOPHRENIA: PROPORTION MONOGENIC HERITABILITY 70-80%

  • A schizophrenia-associated loci was shown to physically interact with and regulate FOXG1 expression

  • Expression of schizophrenia-associated gene, GRID1, found to be significantly elevated in FOXG1 patient-derived iPSC neurons and Foxg1+/- fetal mouse brainFunctional/regulatory elements in FOXG1

EPILEPSY :PROPORTION MONOGENIC – >40% in EPILEPTIC ENCEPHALOPATHIES

  • ~87% of individuals with a FOXG1 mutation are diagnosed with epilepsy

  • Age of onset, seizure type, response to medication variable


 
 
  • All pathogenic missense mutations thought to occur in the forkhead DNA binding domain

  • Deletions including cis-acting regulatory elements but not coding region result in a FOXG1 syndrome phenotype